{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:59:34Z","timestamp":1788580774618,"version":"build-2803163510"},"reference-count":28,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"JSPS KAKENHI","award":["JP21K09293"],"award-info":[{"award-number":["JP21K09293"]}]},{"DOI":"10.13039\/501100004095","name":"Kyowa Kirin Co., Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Loss-of-function variants in the PHEX gene cause X-linked hypophosphatemia (XLH) with inappropriate secretion of fibroblast growth factor 23. The PHEX protein is therefore predicted to be involved in the phosphate (Pi)-sensing mechanism in mature osteocytes. The parathyroid glands sense short-term fluctuations in serum Pi levels and secrete PTH accordingly. However, the precise mechanisms for Pi sensing in the parathyroid gland have not been elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To clarify the involvement of PHEX in phosphate sensing in the parathyroid glands, PTH reactions after Pi loading were retrospectively compared between patients with XLH and those with tumor-induced osteomalacia (TIO).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Serum Pi, intact PTH (iPTH) and albumin-corrected serum calcium (cCa) levels at 1\u2005hour after oral phosphate administration at doses ranging from 300 to 1500\u2005mg were analyzed. The trend of iPTH in each participant was compared between XLH and TIO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Six XLH patients and 13 TIO patients were included. The serum Pi level significantly increased after the oral Pi load, whereas the serum cCa level was stable. The slope of the scatter plot of iPTH (pg\/mL) vs Pi (mg\/dL) after the oral Pi load for each patient was 41.4 (median) in XLH, which was significantly greater than the 7.1 in TIO (P = .034).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>iPTH increased in accordance with Pi levels, with a greater slope observed in XLH than in TIO after oral Pi loading. This finding suggests that PHEX in the parathyroid glands might also determine the serum Pi-sensing threshold and mediate PTH secretion in the case of abrupt fluctuations in serum Pi levels, which may explain the high prevalence of secondary and tertiary hyperparathyroidism in patients with XLH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf357","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T07:49:41Z","timestamp":1749800981000},"page":"e1-e8","source":"Crossref","is-referenced-by-count":3,"title":["PHEX Protein in the Parathyroid Gland Contributes to Phosphate Sensing"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1638-7202","authenticated-orcid":false,"given":"Koki","family":"Irie","sequence":"first","affiliation":[{"name":"Division of Nephrology and Endocrinology, The University of Tokyo Hospital , Tokyo 113-8655 ,","place":["Japan"]},{"name":"Osteoporosis Center, The University of Tokyo Hospital , Tokyo 113-8655 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9178-7846","authenticated-orcid":false,"given":"Hajime","family":"Kato","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, The University of Tokyo Hospital , Tokyo 113-8655 ,","place":["Japan"]},{"name":"Osteoporosis Center, The University of Tokyo Hospital , Tokyo 113-8655 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuho","family":"Adachi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The University of Tokyo Hospital , Tokyo 113-8655 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2385-428X","authenticated-orcid":false,"given":"Soichiro","family":"Kimura","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, The University of Tokyo Hospital , Tokyo 113-8655 ,","place":["Japan"]},{"name":"Osteoporosis Center, The University of Tokyo Hospital , Tokyo 113-8655 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5226-2227","authenticated-orcid":false,"given":"Yoshitomo","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, The University of Tokyo Hospital , Tokyo 113-8655 ,","place":["Japan"]},{"name":"Osteoporosis Center, The University of Tokyo Hospital , Tokyo 113-8655 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5450-2247","authenticated-orcid":false,"given":"Naoko","family":"Hidaka","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, The University of Tokyo Hospital , Tokyo 113-8655 ,","place":["Japan"]},{"name":"Osteoporosis Center, The University of Tokyo Hospital , Tokyo 113-8655 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9210-9414","authenticated-orcid":false,"given":"Sakae","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, The University of Tokyo Hospital , Tokyo 113-8655 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7401-2934","authenticated-orcid":false,"given":"Masaomi","family":"Nangaku","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, The University of Tokyo Hospital , Tokyo 113-8655 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4911-3930","authenticated-orcid":false,"given":"Taku","family":"Saito","sequence":"additional","affiliation":[{"name":"Osteoporosis Center, The University of Tokyo Hospital , Tokyo 113-8655 ,","place":["Japan"]},{"name":"Department of Orthopedic Surgery, The University of Tokyo Hospital , Tokyo 113-8655 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5722-115X","authenticated-orcid":false,"given":"Noriko","family":"Makita","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, The University of Tokyo Hospital , Tokyo 113-8655 ,","place":["Japan"]},{"name":"Osteoporosis Center, The University of Tokyo Hospital , Tokyo 113-8655 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4071-5372","authenticated-orcid":false,"given":"Nobuaki","family":"Ito","sequence":"additional","affiliation":[{"name":"Osteoporosis Center, The University of Tokyo Hospital , Tokyo 113-8655 ,","place":["Japan"]},{"name":"Division of Therapeutic Development for Intractable Bone Diseases, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo , Tokyo 113-8655 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"issue":"3","key":"2025121807420993700_dgaf357-B1","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","article-title":"Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men","volume":"90","author":"Ferrari","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025121807420993700_dgaf357-B2","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","article-title":"Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women","volume":"21","author":"Burnett","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"23","key":"2025121807420993700_dgaf357-B3","doi-asserted-by":"crossref","first-page":"11418","DOI":"10.1073\/pnas.1815166116","article-title":"Activation of unliganded FGF receptor by extracellular phosphate potentiates proteolytic protection of FGF23 by its O-glycosylation","volume":"166","author":"Takashi","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2025121807420993700_dgaf357-B4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41574-022-00662-x","article-title":"Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia","volume":"18","author":"Trombetti","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"2025121807420993700_dgaf357-B5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00774-007-0779-3","article-title":"Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans","volume":"25","author":"Ito","year":"2007","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"2025121807420993700_dgaf357-B6","doi-asserted-by":"crossref","first-page":"E852","DOI":"10.1210\/clinem\/dgab635","article-title":"Acute effects of an inorganic phosphorus additive on mineral metabolism and cardiometabolic risk factors in healthy subjects","volume":"107","author":"Volk","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025121807420993700_dgaf357-B7","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1038\/s41467-019-12399-9","article-title":"Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion","volume":"10","author":"Centeno","year":"2019","journal-title":"Nat Commun"},{"issue":"7","key":"2025121807420993700_dgaf357-B8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s004670050669","article-title":"PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia","volume":"13","author":"Blydt-Hansen","year":"1999","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"2025121807420993700_dgaf357-B9","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/ki.2010.260","article-title":"Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients","volume":"78","author":"Krajisnik","year":"2010","journal-title":"Kidney Int"},{"issue":"9","key":"2025121807420993700_dgaf357-B10","doi-asserted-by":"crossref","first-page":"E3682","DOI":"10.1210\/clinem\/dgab282","article-title":"Incidence of complications in 25 adult patients with X-linked hypophosphatemia","volume":"106","author":"Kato","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025121807420993700_dgaf357-B11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/path.4465","article-title":"Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour","volume":"235","author":"Lee","year":"2015","journal-title":"J Pathol"},{"issue":"11","key":"2025121807420993700_dgaf357-B12","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/modpathol.2016.137","article-title":"Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors","volume":"29","author":"Lee","year":"2016","journal-title":"Mod Pathol"},{"issue":"10","key":"2025121807420993700_dgaf357-B13","doi-asserted-by":"crossref","first-page":"100266","DOI":"10.1016\/j.modpat.2023.100266","article-title":"RNA sequencing reveals novel oncogenic fusions and depicts detailed fusion transcripts of FN1-FGFR1 in phosphaturic mesenchymal tumors","volume":"36","author":"Liu","year":"2023","journal-title":"Mod Pathol"},{"issue":"12","key":"2025121807420993700_dgaf357-B14","doi-asserted-by":"crossref","first-page":"100336","DOI":"10.1016\/j.modpat.2023.100336","article-title":"Klotho overexpression is frequently associated with upstream rearrangements in fusion-negative phosphaturic mesenchymal tumors of bone and sinonasal tract","volume":"36","author":"Lee","year":"2023","journal-title":"Mod Pathol"},{"issue":"8","key":"2025121807420993700_dgaf357-B15","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/jbmr.3475","article-title":"A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis","volume":"33","author":"Insogna","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"21","key":"2025121807420993700_dgaf357-B16","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab therapy in children with X-linked hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"2025121807420993700_dgaf357-B17","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jbmr.4184","article-title":"Interim analysis of a phase 2 open-label trial assessing burosumab efficacy and safety in patients with tumor-induced osteomalacia","volume":"36","author":"Imanishi","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2025121807420993700_dgaf357-B18","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/jbmr.4620","article-title":"Clinical challenges in diagnosis, tumor localization and treatment of tumor-induced osteomalacia: outcome of a retrospective surveillance","volume":"37","author":"Hidaka","year":"2022","journal-title":"J Bone Miner Res"},{"key":"2025121807420993700_dgaf357-B19","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bone.2019.06.025","article-title":"Hyperparathyroidism and parathyroidectomy in X-linked hypophosphatemia patients","volume":"127","author":"DeLacey","year":"2019","journal-title":"Bone"},{"issue":"5","key":"2025121807420993700_dgaf357-B20","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1210\/clinem\/dgac650","article-title":"Hyperparathyroidism in a large cohort of Chinese patients with tumor-induced osteomalacia","volume":"108","author":"Ni","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025121807420993700_dgaf357-B21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00774-015-0698-7","article-title":"Pathogenesis and diagnostic criteria for rickets and osteomalacia\u2014proposal by an expert panel supported by the Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research, and the Japan Endocrine Society","volume":"33","author":"Fukumoto","year":"2015","journal-title":"J Bone Miner Metab"},{"issue":"6","key":"2025121807420993700_dgaf357-B22","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s00774-021-01250-1","article-title":"Clinical performance of a novel chemiluminescent enzyme immunoassay for FGF23","volume":"39","author":"Ito","year":"2021","journal-title":"J Bone Miner Metab"},{"issue":"5","key":"2025121807420993700_dgaf357-B23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMc2405746","article-title":"Acquired osteomalacia associated with autoantibodies against PHEX","volume":"392","author":"Hoshino","year":"2025","journal-title":"N Engl J Med"},{"key":"2025121807420993700_dgaf357-B24","doi-asserted-by":"crossref","unstructured":"Irie K, Kato H, Adachi N, et al \u00a0Supplementary materials for PHEX protein in the parathyroid gland contributes to phosphate sensing. Figshare. Deposited June 17, 2025. 10.6084\/m9.figshare.29322902","DOI":"10.1210\/clinem\/dgaf357"},{"issue":"12","key":"2025121807420993700_dgaf357-B25","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J Clin Invest"},{"key":"2025121807420993700_dgaf357-B26","doi-asserted-by":"crossref","first-page":"40534","DOI":"10.1038\/srep40534","article-title":"Persistent fibroblast growth factor 23 signalling in the parathyroid glands for secondary hyperparathyroidism in mice with chronic kidney disease","volume":"7","author":"Kawakami","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"2025121807420993700_dgaf357-B27","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/jcb.25742","article-title":"Extracellular phosphate induces the expression of dentin matrix protein 1 through the FGF receptor in osteoblasts","volume":"118","author":"Nishino","year":"2017","journal-title":"J Cell Biochem"},{"issue":"7","key":"2025121807420993700_dgaf357-B28","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician's guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J Bone Miner Res"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf357\/63485758\/dgaf357.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/1\/e1\/63485758\/dgaf357.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/1\/e1\/63485758\/dgaf357.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T12:42:37Z","timestamp":1766061757000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/1\/e1\/8161764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,6,13]]},"published-print":{"date-parts":[[2025,12,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf357","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,6,13]]}}}